TLPH · Talphera, Inc.
$1.23
+0.04 (+3.36%)
At close · Aug 25
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern. While management believes its plans to raise additional funds will alleviate the conditions that raise substantial doubt about the Company's ability to continue as a going concern, these plans are not entirely within the Company's control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Market Cap
$61.77M
Shares
51.91M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$28K
FY2025
Net Income
-$14.29M
-9.9%
FY2025
Gross Margin
-33.18%
-21.8pp
FY2021
Operating Margin
-48157.14%
FY2025
Diluted EPS
-$1.29
-122.6%
FY2023
Operating Cash Flow
-$11.36M
+10.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1000 | $28K | $0 | $651K | $0 | $2.82M | $5.42M | $2.29M | $2.15M | $8M | $17.36M | $19.26M | $5.22M | $29.5M | $2.39M | $1.07M | — | — | — | — | — | |
| — | — | — | — | $2.59M | $3.75M | $6.03M | $6.81M | $3.98M | $10.66M | $12.32M | $1.77M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | -$2.59M | -$935K | -$616K | -$4.52M | -$1.83M | -$2.66M | $5.04M | $17.49M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | -33.18% | -11.37% | -197.34% | -84.84% | -33.32% | 29.05% | 90.81% | — | — | — | — | — | — | — | — | — | |
| $6.7M | $6.03M | $6.72M | $5.55M | $3.34M | $4.1M | $4.02M | $4.66M | $13.14M | $19.41M | $21.4M | $22.49M | $24.52M | $26.29M | $24.91M | $13.62M | $8.19M | $15.5M | — | — | — | |
| — | — | — | — | — | — | — | — | $20.77M | $16.61M | $15.6M | $14.2M | $18.35M | $9.88M | $7.2M | $6.8M | $3.99M | $3.53M | — | — | — | |
| $8.04M | $7.48M | $8.53M | $11.99M | $17.01M | $30.94M | $36.33M | $45.03M | $20.77M | $16.61M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $0 | $311K | $1.65M | $1.97M | $1.85M | $1.67M | $575K | $1.74M | $2.05M | $1.98M | $866K | $593K | $605K | $513K | $479K | $481K | — | — | — | |
| — | — | — | — | $500K | — | $500K | — | — | — | — | $756K | — | — | — | — | — | — | — | — | — | |
| $56.49M | — | — | — | — | — | — | — | $37.88M | $46.68M | $49.31M | $39.22M | $42.87M | $36.17M | $32.11M | $20.42M | $12.19M | $19.03M | — | — | — | |
| $14.75M | $13.51M | $15.25M | $17.54M | $25.3M | $38.78M | $46.38M | $56.49M | $37.88M | $46.68M | — | — | — | — | — | — | — | — | — | — | — | |
| -$14.75M | -$13.48M | -$15.25M | -$16.89M | -$25.3M | -$35.97M | -$40.96M | -$54.21M | -$35.73M | -$38.68M | -$31.96M | -$19.95M | -$37.65M | -$6.67M | — | — | — | — | — | — | — | |
| — | -48157.14% | — | -2594.32% | — | -1276.26% | -756.33% | -2368.06% | -1660.95% | -483.83% | -184.12% | -103.59% | -721.66% | -22.6% | — | — | — | — | — | — | — | |
| — | — | -$15.25M | -$16.58M | -$23.65M | -$33.99M | -$39.11M | -$52.54M | -$35.15M | -$36.94M | -$29.91M | -$17.97M | -$36.78M | -$6.07M | — | — | — | — | — | — | — | |
| — | — | $0 | $134K | $1.12M | $2.29M | $3.31M | $2.54M | $2.22M | $3.32M | $2.77M | $2.98M | $2.64M | $1.52M | $2.28M | $2.31M | $1.4M | $1.24M | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $52K | $4000 | $33K | — | — | — | |
| -$329K | -$879K | $2.25M | $6.6M | $84.44M | $871K | $588K | $968K | -$11.42M | -$13.53M | -$11.23M | -$3.69M | $4.3M | -$16.76M | -$1.37M | $1.56M | -$761K | $121K | — | — | — | |
| — | — | — | -$10.29M | $59.14M | -$35.09M | -$40.38M | -$53.24M | -$47.15M | -$52.21M | -$43.19M | -$23.64M | -$37.65M | -$6.67M | -$29.71M | -$19.35M | -$12.19M | -$19.03M | — | — | — | |
| — | $0 | $0 | $0 | $13K | $5000 | $4000 | $3000 | $2000 | -$701K | -$34K | $760K | $0 | $0 | $0 | $0 | — | — | — | — | — | |
| -$15.08M | -$14.29M | -$13M | -$18.4M | $47.76M | -$35.1M | -$40.38M | -$53.24M | -$47.15M | -$51.51M | -$43.16M | -$24.4M | -$33.35M | -$23.43M | -$33.36M | -$20.1M | -$14.34M | -$20.12M | -$20.66M | -$9.63M | -$3.77M | |
| — | -51035.71% | — | -2825.96% | — | -1245.53% | -745.55% | -2325.91% | -2191.96% | -644.25% | -248.64% | -126.66% | -639.31% | -79.4% | -1393.61% | -1875.09% | — | — | — | — | — | |
| — | — | — | -$18.4M | $42.33M | -$35.1M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | -$35.1M | -$40.38M | -$53.24M | -$47.15M | -$51.51M | -$43.15M | -$24.4M | -$33.36M | -$23.43M | -$33.36M | -$20.1M | -$14.34M | -$20.16M | -$20.63M | -$9.62M | -$3.77M | |
| USD/shares | — | -$0.34 | -$0.50 | -$1.29 | $5.73 | -$5.86 | — | — | — | -$22.00 | -$19.00 | -$11.00 | -$15.40 | -$11.80 | -$30.20 | — | — | — | — | — | — |
| USD/shares | — | — | — | -$1.29 | $5.72 | -$5.86 | — | — | — | -$22.00 | -$19.00 | -$12.00 | -$18.20 | -$11.80 | -$30.20 | — | — | — | — | — | — |
| shares | — | 42.41M | 25.85M | 14.26M | 7.39M | 5.99M | 4.26M | 3.96M | 2.92M | 2.34M | 2.27M | 2.22M | 2.17M | 1.99M | 1.11M | 867.24K | 32.83K | — | — | — | — |
| shares | — | — | — | 14.26M | 7.41M | 5.99M | 4.26M | 3.96M | 2.92M | 2.34M | 2.27M | 2.22M | 2.22M | 1.99M | 1.11M | 867.24K | 32.83K | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.21×
EV/EBIT
—
Peer median 8.55×
P/E (TTM)
—
Peer medians compare against the 43 similar-size Drug Manufacturers - Specialty & Generic companies (of 102 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Product | $1,771,000 | $1,005,000 | $2,521,000 | $1,830,000 | $825,000 |
| DSUVIA | $1,588,000 | $735,000 | $1,409,000 | $377,000 | $0 |
| DZUVEO | $183,000 | $0 | — | — | — |
| Contract and Other Collaboration | $0 | $1,813,000 | $2,895,000 | $459,000 | $1,326,000 |
| Contract and Other Revenue | $0 | $6,000 | $2,572,000 | $43,000 | $103,000 |
| Non-Cash Royalty | $0 | $83,000 | $242,000 | $312,000 | $289,000 |
| ZALVISO | $0 | $270,000 | $1,112,000 | $1,453,000 | $825,000 |
| License | $0 | $1,696,000 | $0 | — | — |
| Royalty | $0 | $28,000 | $81,000 | $104,000 | $96,000 |
| Amended License Agreement | — | — | $3,683,000 | $1,496,000 | — |
| Department of Defense | — | — | $0 | $0 | $838,000 |
Key facts
CIK
1427925
CUSIP
00444T209
13F (30d)
48 filings
47 filers
Visit website
Investor relations